via foxbusiness.com
LONDON – AstraZeneca PLC (AZN.LN), the biopharmaceutical business, Monday announced that the U.S. District Court for the District of Columbia issued an opinion and order in AstraZeneca's lawsuit against the U.S. Food and Drug Administration regarding final marketing approval of generic quetiapine, adding that the Court denied the company's request for a preliminary injunction and dismissed the lawsuit without prejudice.
Read more: http://www.foxbusiness.com/news/2012/03/26/astrazeneca-us-court-dismisses-fda...?#ixzz1qCfzot6D
No comments:
Post a Comment